Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Person › Details

Markus Dangl (Medigene AG (FSE: MDG1, Prime Standard))

Dangl, Markus (Medigene 201603– SVP Research + Pre-Clinical Development before Roche Diagnostics GmbH)

 

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Former/major organisation Roche Diagnostics GmbH
  Group Roche (Group)
Products Product clinical research
  Product 2 cancer immunotherapy (immuno-oncology, I-O)
     

   
Record changed: 2018-02-20

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px


More documents for Markus Dangl


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top